Search Results 331-340 of 18103 for Lymphocytic leukemia

  1. A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT) - Mayo Clinic

    A Study to Evaluate Daratumumab and Ibrutinib to Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT) ... CLL/SLL therapy. Note ...

  2. Faculty and staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Lymphoma Epidemiology: James R. Cerhan · Case-Control Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular Epidemiology ...

  3. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. ... leukemia that has come back (recurrent) or that does not ...

  4. Targeted Drug with Chemotherapy Combo Offers Longer Life to Patients with B-cell Cancers - Mayo Clinic News Network

    ... lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), an interim analysis has closed the international HELIOS phase III clinical trial. Led by ...

  5. Clinical trials - Oncology (Medical)

    ... lymphocytic leukemia (CLL) risk across African Americans, Hispanics, and Caucasian populations. ... leukemia that has come back (recurrent) or that does not ...

  6. Clinical trials - Oncology (Medical)

    A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls. Rochester, Minn ...

  7. Faculty and staff - Lymphoma Epidemiology Laboratory - Mayo Clinic Research

    Overview · Faculty and staff · Research Research. Case-Control Study of Hodgkin Lymphoma, Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia · Molecular ...

  8. CAR-T Cell Therapy Program - Doctors - Mayo Clinic

    ... lymphocytic leukemia, Multiple m...yeloma, POEMS syndrome, Waldenstrom macroglobulinemia, Monoclonal gammopathy of undetermined significance, Plasma cell ...

  9. Hematology - Clinical trials

    Anticipated time on study is up to 5 years. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL) ...

  10. A Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics (PK/PD) in Patients With Hematologic Malignancies - Mayo Clinic

    malignancies including multiple myeloma, chronic lymphocytic leukemia, ... lymphoblastic lymphoma/leukemia. 3. Received chemotherapy within 14 days (42 ...